Edwards Lifesciences Corp logo

Edwards Lifesciences Corp EW

Market Closed
18 Jun, 20:00
NYSE NYSE
$
88. 52
+1.65
+1.9%
Pre Market
$
86. 50
-2.02 -2.28%
54.3B Market Cap
32.12 P/E Ratio
0% Div Yield
3,710,000 Volume
2.51 Eps
$ 86.87
Previous Close
Day Range
86.2 89
Year Range
60.57 96.12

EW Chart

Edwards Lifesciences Corp Profile

Medical Devices Industry
Healthcare Sector
Mr. Bernard J. Zovighian CEO
NYSE Exchange
US28176E1082 ISIN
US Country
19,800 Employees
- Last Dividend
14 Dec 2015 Last Split
27 Mar 2000 IPO Date

Overview

Edwards Lifesciences Corporation specializes in providing advanced medical technologies tailored to diagnose and treat structural heart diseases and conditions requiring critical care monitoring. The company has a global footprint, offering its state-of-the-art products and solutions across the United States, Europe, Japan, and other international markets. Founded in 1958, Edwards Lifesciences has its headquarters in Irvine, California, and leverages both a direct sales force and a network of independent distributors to reach its market.

Products and Services

  • Transcatheter Heart Valve Replacement Products:

    Under the Edwards SAPIEN family, these products offer minimally invasive options for replacing aortic heart valves, enabling significant improvements in patient outcomes and recovery times.

  • Transcatheter Heart Valve Repair and Replacement Products:

    Targeting mitral and tricuspid valve diseases, products under the PASCAL PRECISION and Cardioband names offer advanced solutions for valve repair and replacement, supporting heart function restoration.

  • Surgical Structural Heart Solutions:

    Edwards provides various surgical solutions including the INSPIRIS aortic surgical valve and the INSPIRIS RESILLA valve, featuring RESILIA tissue and VFit technology for enhanced durability. The KONECT RESILIA and MITRIS RESILIA valve products support complex procedures with pre-assembled tissue valves and innovative designs for better patient outcomes.

  • Critical Care Solutions:

    The company's critical care portfolio includes hemodynamic monitoring systems such as FloTrac, Acumen IQ sensors, ClearSight, Acumen IQ cuffs, and ForeSight, designed to measure heart function and fluid status in surgical and ICU settings accurately. The HemoSphere monitoring platform visually displays critical physiological information, and the Acumen Hypotension Prediction Index software utilizes advanced algorithms to predict and alert clinicians of potential dangerous drops in blood pressure.

Contact Information

Address: One Edwards Way, Irvine, CA, United States, 92614
Phone: 949 250 2500